|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0025723,
umls-concept:C0079772,
umls-concept:C0085862,
umls-concept:C0205225,
umls-concept:C0249219,
umls-concept:C0591833,
umls-concept:C0809183,
umls-concept:C0919418,
umls-concept:C1152568,
umls-concept:C1332739,
umls-concept:C1442161,
umls-concept:C1511576,
umls-concept:C1515568,
umls-concept:C1515926,
umls-concept:C2362057
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
1997-7-14
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
A wide panel of murine induced T-cell lymphomas have been analysed for p16INK4a or p15INK4b alterations. Only one gamma-radiation-induced lymphoma showed p16INK4a homozygous deletion and no other intragenic mutations were found in these INK4 genes. However, de novo methylation of the 5' CpG islands of the murine p15INK4b and p16INK4a genes was found to be highly frequent. While p16INK4a hypermethylation was found in 36% of the neutron-radiation-induced lymphomas and 15% of the gamma-radiation-induced lymphomas, de novo methylation of p15INK4b occurs in 88% and 42% of these tumors respectively, correlating with deficient expression of the corresponding mRNA and allelic losses in the p15INK4b and p16INK4a chromosome location. These data represent, to our knowledge, the first report on the significant involvement of hypermethylation of these INK4 genes in murine primary tumors. Moreover, they show the importance of allelic losses and CpG island methylation of p15INK4b gene inactivation and support a tumor suppressor role for p15INK4b in T-cell lymphomas independent of p16INK4a.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0950-9232
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
20
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1361-70
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:9178896-Animals,
pubmed-meshheading:9178896-Carrier Proteins,
pubmed-meshheading:9178896-Cell Cycle Proteins,
pubmed-meshheading:9178896-CpG Islands,
pubmed-meshheading:9178896-Cyclin-Dependent Kinase Inhibitor p15,
pubmed-meshheading:9178896-Cyclin-Dependent Kinase Inhibitor p16,
pubmed-meshheading:9178896-DNA Methylation,
pubmed-meshheading:9178896-Gene Deletion,
pubmed-meshheading:9178896-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:9178896-Lymphoma, T-Cell,
pubmed-meshheading:9178896-Mice,
pubmed-meshheading:9178896-Mice, Inbred Strains,
pubmed-meshheading:9178896-Molecular Sequence Data,
pubmed-meshheading:9178896-Polymorphism, Single-Stranded Conformational,
pubmed-meshheading:9178896-Tumor Suppressor Proteins
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Inactivation of the cyclin-dependent kinase inhibitor p15INK4b by deletion and de novo methylation with independence of p16INK4a alterations in murine primary T-cell lymphomas.
|
|
pubmed:affiliation |
Department of Pathology and Kaplan Comprehensive Cancer Center, New York University Medical Center, New York 10016, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
